Journals / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: SI-1

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

Pages
192–202
Publication Date
2020-06-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2.
📊
Key Findings & Data:The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak.
💡
Conclusion & Impact:This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:COVID-19 · SARS-CoV-2 · coronavirus

Abstract

The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

🔖

Cite This Article

TASTAN, C., YURTSEVER, B., KARAKUS, G. S., KANCAGİ, D. D., DEMİR, S., ABANUZ, S., SEYİS, U., YİLDİRİM, M., KUZAY, R., ELİBOL, O., ARBAK, S., ELMAS, M. A., BİRDOGAN, S., SEZERMAN, O. U., KOCAGOZ, A. S., YALCİN, K., OVALİ, E. (2020). SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients. Turkish Journal of Biology, Cilt: 44 - Sayı: SI-1, 192–202. https://ajindex.com/articles/204385

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9 Baer A, 2014,
  2. JOVE-J VIS EXP, DOI 10.3791/52065 Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9 Guallart N, 2015,
  3. AXIOMATHES, V25, P61, DOI 10.1007/s10516-014-9260-9 Harcourt Jennifer, 2020, bioRxiv, DOI 10.1101/2020.03.02.972935 He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067 Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191 Honda-Okubo Y, 2015, J VIROL, V89, P2995, DOI 10.1128/JVI.02980-14 Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009 Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490 Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316 Libraty DH, 2007,
  4. VIROLOGY, V368, P317, DOI 10.1016/j.virol.2007.07.015 Liu W, 2020, ATTACKS 1 BETA CHAIN, DOI [10.26434/chemrxiv, DOI 10.26434/CHEMRXIV] Masters P.S., 2013, FIELDS VIROLOGY, P825 Matsumoto Mitsuyo, 2005, Animal Science Journal, V76, P507, DOI 10.1111/j.1740-0929.2005.00297.x Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212 STOHL W, 1987, CLIN EXP IMMUNOL, V70, P649 Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2 Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013 Zheng J, 2020, INT J BIOL SCI, V16, P1678, DOI 10.7150/ijbs.45053 Zhou P, 2020,
  5. NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7